Marc Zapatka
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experience.
Journal: International journal of cancer
Published: June 27, 2025
Author Correction: Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instability.
Journal: Nature communications
Published: January 27, 2025
Pipeline Olympics: continuable benchmarking of computational workflows for DNA methylation sequencing data against an experimental gold standard.
Journal: Nucleic acids research
Published: December 14, 2024
COGNITION-GUIDE - Genomics-Guided Targeted Post-Neoadjuvant Therapy in Patients with Early Breast Cancer: Study Design of a Multicenter, Open-Label, Umbrella Phase II Study.
Journal: Geburtshilfe und Frauenheilkunde
Published: October 23, 2024
Biopsy-derived organoids in personalised early breast cancer care: Challenges of tumour purity and normal cell overgrowth cap their practical utility.
Journal: International journal of cancer
Published: July 05, 2024
Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instability.
Journal: Nature communications
Published: April 08, 2024
Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target.
Journal: Nature communications
Published: January 29, 2024
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.
Journal: Blood
Published: July 31, 2023
Conumee 2.0: enhanced copy-number variation analysis from DNA methylation arrays for humans and mice.
Journal: Bioinformatics (Oxford, England)
Published: June 30, 2023
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL.
Journal: Nature communications
Published: June 19, 2023
Last Updated: 09/26/2026